R A Mulnard

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study
    R A Mulnard
    Institute for Brain Aging and Dementia, University of California, Irvine 92697 4540, USA
    JAMA 283:1007-15. 2000
  2. ncbi Translational research: connecting evidence to clinical practice
    Ruth A Mulnard
    Program in Nursing Science, Institute for Clinical and Translational Science, University of California Irvine, Irvine, California, USA
    Jpn J Nurs Sci 8:1-6. 2011
  3. ncbi Methodological issues in estrogen treatment trials for Alzheimer's disease
    Ruth A Mulnard
    Department of Neurology, Institute for Brain Aging and Dementia, 1113 Gillespie Neuroscience Research Facility, University of California Irvine, Irvine, CA 92697 4540, USA
    Ann N Y Acad Sci 1052:173-81. 2005
  4. ncbi Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment
    Ruth A Mulnard
    Departments of Neurology, and Neurobiology and Behavior, University of California Irvine, Gillespie NRF, Room 1113, Irvine, CA 92697 4540, USA
    Curr Neurol Neurosci Rep 4:368-73. 2004
  5. ncbi Writing an application for a human subjects institutional review board
    Henri G Colt
    Department of Pulmonary and Critical Care Medicine, University of California Irvine, Orange, CA 92868, USA
    Chest 130:1605-7. 2006
  6. ncbi Steroid-induced elevation of glucose in Alzheimer's disease: relationship to gender, apolipoprotein E genotype and cognition
    P S Aisen
    Department of Neurology, Georgetown University Medical Center, 1Bles Building, 3800 Reservoir Road NW, Washington, DC 20007, USA
    Psychoneuroendocrinology 28:113-20. 2003
  7. ncbi High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
    Paul S Aisen
    Department of Neurosciences, University of California, San Diego, 9500 Gilman Dr, M C 0949, La Jolla, CA 92093, USA
    JAMA 300:1774-83. 2008
  8. ncbi Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects
    E C Mormino
    Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA
    Brain 132:1310-23. 2009
  9. ncbi Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease
    David A Wolk
    Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Proc Natl Acad Sci U S A 107:10256-61. 2010
  10. ncbi Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria
    Edmond Teng
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90073, USA
    Am J Geriatr Psychiatry 16:469-77. 2008

Detail Information

Publications10

  1. ncbi Estrogen replacement therapy for treatment of mild to moderate Alzheimer disease: a randomized controlled trial. Alzheimer's Disease Cooperative Study
    R A Mulnard
    Institute for Brain Aging and Dementia, University of California, Irvine 92697 4540, USA
    JAMA 283:1007-15. 2000
    ..Several reports from small clinical trials have suggested that estrogen replacement therapy may be useful for the treatment of Alzheimer disease (AD) in women...
  2. ncbi Translational research: connecting evidence to clinical practice
    Ruth A Mulnard
    Program in Nursing Science, Institute for Clinical and Translational Science, University of California Irvine, Irvine, California, USA
    Jpn J Nurs Sci 8:1-6. 2011
    ....
  3. ncbi Methodological issues in estrogen treatment trials for Alzheimer's disease
    Ruth A Mulnard
    Department of Neurology, Institute for Brain Aging and Dementia, 1113 Gillespie Neuroscience Research Facility, University of California Irvine, Irvine, CA 92697 4540, USA
    Ann N Y Acad Sci 1052:173-81. 2005
    ..Design variations among these trials may account for the inconsistent results of these investigations and the persistent gap in knowledge about the appropriate use of estrogen in the treatment paradigm for degenerative diseases...
  4. ncbi Estrogen replacement therapy, Alzheimer's disease, and mild cognitive impairment
    Ruth A Mulnard
    Departments of Neurology, and Neurobiology and Behavior, University of California Irvine, Gillespie NRF, Room 1113, Irvine, CA 92697 4540, USA
    Curr Neurol Neurosci Rep 4:368-73. 2004
    ..Additional basic and clinical investigations are necessary to examine different forms and dosages of estrogens, other populations, and the relevance of timing and duration of exposure...
  5. ncbi Writing an application for a human subjects institutional review board
    Henri G Colt
    Department of Pulmonary and Critical Care Medicine, University of California Irvine, Orange, CA 92868, USA
    Chest 130:1605-7. 2006
    ....
  6. ncbi Steroid-induced elevation of glucose in Alzheimer's disease: relationship to gender, apolipoprotein E genotype and cognition
    P S Aisen
    Department of Neurology, Georgetown University Medical Center, 1Bles Building, 3800 Reservoir Road NW, Washington, DC 20007, USA
    Psychoneuroendocrinology 28:113-20. 2003
    ..These results support a relationship between gender, apolipoprotein E genotype and glucose metabolism, but do not indicate that mild changes in glucose have an important impact on cognitive function...
  7. ncbi High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial
    Paul S Aisen
    Department of Neurosciences, University of California, San Diego, 9500 Gilman Dr, M C 0949, La Jolla, CA 92093, USA
    JAMA 300:1774-83. 2008
    ..Prior studies of B vitamins to reduce homocysteine in AD have not had sufficient size or duration to assess their effect on cognitive decline...
  8. ncbi Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects
    E C Mormino
    Helen Wills Neuroscience Institute, University of California, Berkeley, Berkeley, CA 94720, USA
    Brain 132:1310-23. 2009
    ..This pattern suggests that declining EM in older individuals may be caused by Abeta-induced hippocampus atrophy...
  9. ncbi Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease
    David A Wolk
    Department of Neurology, University of Pennsylvania, Philadelphia, PA 19104, USA
    Proc Natl Acad Sci U S A 107:10256-61. 2010
    ....
  10. ncbi Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria
    Edmond Teng
    Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90073, USA
    Am J Geriatr Psychiatry 16:469-77. 2008
    ....